Cargando…

Genetic analysis of a novel antioxidant multi-target iron chelator, M30 protecting against chemotherapy-induced alopecia in mice

BACKGROUND: Chemotherapy-induced alopecia has been well documented as a cause of distress to patients undergoing cancer treatment. Almost all traditional chemotherapeutic agents cause severe alopecia. Despite advances in the treatment of chemotherapy-induced alopecia, there is no effective treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Young-Cheol, Kim, Hyeongi, Lim, Sang Moo, Kim, Jin Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374887/ https://www.ncbi.nlm.nih.gov/pubmed/30760223 http://dx.doi.org/10.1186/s12885-019-5323-z

Ejemplares similares

A Novel Antioxidant Multitarget Iron Chelator M30 Protects Hepatocytes against Ethanol-Induced Injury
por: Xiao, Jia, et al.
Publicado: (2015)

Combination Radioimmunotherapy Strategies for Solid Tumors
por: Zaheer, Javeria, et al.
Publicado: (2019)

Comparison between Fractionated Dose and Single Dose of Cu-64 Trastuzumab Therapy in the NCI-N87 Gastric Cancer Mouse Model
por: Zaheer, Javeria, et al.
Publicado: (2019)

Antioxidant and free radical scavenging activity of iron chelators
por: Adjimani, Jonathan P., et al.
Publicado: (2015)

Effects of oral iron chelator deferasirox on human malignant lymphoma cells
por: Choi, Jong Gwon, et al.
Publicado: (2012)

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Combined Therapy of Iron Chelator and Antioxidant Completely Restores Brain Dysfunction Induced by Iron Toxicity
por: Sripetchwandee, Jirapas, et al.
Publicado: (2014)

Chelator-Free Copper-64-Incorporated Iron Oxide Nanoparticles for PET/MR Imaging: Improved Radiocopper Stability and Cell Viability
por: Jang, Hye Min, et al.
Publicado: (2022)

Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats
por: Wongjaikam, Suwakon, et al.
Publicado: (2016)

Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice
por: Aalikhani, Mahdi, et al.
Publicado: (2022)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci
por: Kim, Choon-Mee, et al.
Publicado: (2009)

Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children
por: Lee, J W, et al.
Publicado: (2009)

Synthesis and antioxidant evaluation of some novel ortho-hydroxypyridine-4-one iron chelators
por: Mohammadpour, M., et al.
Publicado: (2012)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia
por: Lin, Chia-Shuen, et al.
Publicado: (2023)

A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy
por: Lim, Shen-Yang, et al.
Publicado: (2018)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Tackling Chemotherapy-induced Alopecia
por: Gude, Dilip
Publicado: (2012)

Comparison of the Effects of DOTA and NOTA Chelators on (64)Cu-Cudotadipep and (64)Cu-Cunotadipep for Prostate Cancer
por: Lee, Inki, et al.
Publicado: (2023)

Antioxidant, Iron Chelating and Tyrosinase Inhibitory Activities of Extracts from Talinum triangulare Leach Stem
por: Oliveira Amorim, Ana Paula, et al.
Publicado: (2013)

The mono(catecholamine) derivatives as iron chelators: synthesis, solution thermodynamic stability and antioxidant properties research
por: Zhang, Qingchun, et al.
Publicado: (2018)

Nano and chelated iron fertilization influences marketable yield, phytochemical properties, and antioxidant capacity of tomatoes
por: Rahman, Arifur, et al.
Publicado: (2023)

Alopecia Areata in the Elderly: A 10-Year Retrospective Study
por: Jang, Yong Hyun, et al.
Publicado: (2015)

Successful Treatment of Alopecia Areata with Topical Calcipotriol
por: Kim, Dong Ha, et al.
Publicado: (2012)

Strategies of Eradicating Glioma Cells: A Multi-Scale Mathematical Model with MiR-451-AMPK-mTOR Control
por: Kim, Yangjin, et al.
Publicado: (2015)

A Review on Iron Chelators in Treatment of Iron Overload Syndromes
por: Mobarra, Naser, et al.
Publicado: (2016)

Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants
por: Gutbier, Simon, et al.
Publicado: (2020)

Lycium Barbarum Polysaccharide-Iron (III) Chelate as Peroxidase Mimics for Total Antioxidant Capacity Assay of Fruit and Vegetable Food
por: Shi, Shuo, et al.
Publicado: (2021)

Chelators in the Treatment of Iron Accumulation in Parkinson's Disease
por: Mounsey, Ross B., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tho6qp2hs4dr3re5kfj27a05r4